Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment—A report from ICTHIC 2021
Open Access
- 1 July 2022
- journal article
- review article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 6 (5) , e12744
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR studyBMJ Open, 2013
- Antithrombotic Therapy in Neonates and ChildrenChest, 2012
- Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2011
- Bleeding events in bevacizumab-treated cancer patients who received full-dose anticoagulation and remained on studyBritish Journal of Cancer, 2011
- Prediction of venous thromboembolism in cancer patientsBlood, 2010
- Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort studyBlood, 2010
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Thromboembolism in children with lymphomaThrombosis Research, 2008
- Mechanisms of adverse effects of anti-VEGF therapy for cancerBritish Journal of Cancer, 2007
- In proven deep vein thrombosis, a low positive D-Dimer score is a strong negative predictor for associated malignancyThrombosis and Haemostasis, 2004